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Halt the hedgehog
Basal cell carcinoma (BCC), the most common skin cancer in 
the United States, is associated with mutations that activate 
the hedgehog signaling pathway to mediate unchecked prolif-
eration of basal cells. A phase I trial was performed to evalu-
ate the effects of daily treatment with GDC-0449, a selective 
hedgehog pathway inhibitor with notable antitumor activity, 
on patients with metastatic or locally advanced BCCs that 
were not amenable to typical surgical, radio-, or systemic 
therapies. Eighteen of the 33 enrolled patients responded to 
GDC-0449 treatment. No grade 5 adverse effects and only one 
grade 4 adverse effect were reported. High mRNA expression 
of the transcription factor GLI1, which induces hedgehog tar-
get genes, was observed in tumors from these patients. Taken 
together, these results support the notion that activation of the 
hedgehog pathway is critical for the growth and maintenance 
of advanced BCC. (N Engl J Med 361:1164–72, 2009)
Information cascade
Using data regarding the claim that β-amyloid, which is 
involved in brain injury in Alzheimer’s disease, is also pro-
duced by and injures skeletal muscle fibers in patients with 
sporadic inclusion body myositis, Steven Greenberg conduct-
ed an analysis of the citation network and the use of these 
references to solidify belief in these scientific claims. The 242 
papers and 675 citations addressing this belief were combined 
to generate a network of 220,553 supporting citation paths. 
Using computational methods, four primary data papers, five 
model papers, and one review that supported this claim were 
identified as the most authoritative publications. Interestingly, 
six data papers that refuted this claim received little or no cita-
tion activity (only 6% of the citation activity). In perpetuating 
this information cascade, primary data that weakened or refut-
ed the claims were ignored (citation bias), some influential 
papers and citations were exponentially cited (amplification), 
and related claims were issued as fact (invention). These cita-
tion distortions resulted in acceptance of this belief according 
to social network theory. (BMJ 339:b2680, 2009)
Chemokine target for psoriasis treatment
Although psoriasis is one of the most common immune-
mediated chronic inflammatory skin disorders, its underly-
ing autoimmune mechanisms are far from clear. Psoriatic 
skin lesions exhibit high levels of IL-23, which functions as 
a key differentiation and growth factor for T helper type 17 
(Th17) cells. In support of a role for the IL-23/Th17 axis in 
psoriasis, injection of IL-23 into mice induces some psorias-
iform changes, although not all the aspects of human disease 
are replicated by this model. Hedrick and colleagues dis-
covered that the chemokine receptor CCR6 is required for 
psoriasiform inflammation induced by intradermal injection 
of IL-23. Surprisingly, this inflammation did not occur via a 
direct effect on T cells but rather via a T-cell-independent 
inflammatory response. These results support therapeu-
tic targeting of this chemokine receptor in Th17-driven 
diseases, especially because blockade of a chemokine 
receptor may actually cause less overall immuno-
suppression than broad-spectrum immune modulators. 
(J Clin Invest 119:2317–29, 2009)
Another source of melanocytes
During development, melanocytes are thought to arise from 
neural crest cells (NCCs) from the neural tube. These NCCs 
acquire a melanocyte fate, migrate dorsolaterally to populate 
the epidermis, and expand to generate 5–10% of the epider-
mal cells. In addition to confirming this model, Adameyko 
and colleagues demonstrated that large numbers of mel-
anocytes are produced from nerves that innervate the skin. 
Specifically, the emergence of melanocytes is associated with 
Schwann cell precursors (SCPs). A strong correlation between 
nerves and Schwann cell phenotypes indicated that cells in 
contact with nerves retained an SCP state and eventually dif-
ferentiated into Schwann cells, whereas cells that detached 
from the nerve acquired Mitf expression, which is indicative 
of the melanocyte lineage. Neuregulin and soluble signals, 
including insulin-like growth factor and platelet-derived 
growth factor, function via competing signals to instruct dif-
ferentiation of SCPs toward Schwann cells or melanocytes. 
Thus, these results implicate SCPs as an additional cellular 
origin of melanocytes. (Cell 139:366–79, 2009)
Dichotomy between benign  
and malignant
Quite often, clinically benign tumors fail to progress to malig-
nant tumors for reasons that have not yet been elucidated. 
Recently, Mandinova and colleagues compared the gene 
expression profiles of benign seborrheic keratoses (SKs) and 
malignant squamous cell carcinomas (SCCs). The tyrosine 
kinase receptor fibroblast growth factor receptor-3 (FGFR3) 
and the transcription factor forkhead box N1 (FOXN1) were 
upregulated in SKs and suppressed in SCCs. A positive feed-
back loop in which activating mutations of FGFR3 induce 
FOXN1 expression, which then leads to increased FGFR3 
expression, locks the keratinocytes into a differentiation 
mode and prevents malignant transformation. This positive 
regulatory loop, therefore, underlies the dichotomy between 
benign and malignant tumor phenotypes in skin. This 
model suggests that shifting the gene expression patterns of 
malignant tumors toward that of benign lesions may be thera-
peutically beneficial. (J Clin Invest 119:3127–37, 2009)
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